CDT Equity Inc. (formerly Conduit Pharmaceuticals Inc.) is a clinical-stage specialty biopharmaceutical company based in Naples, Florida. The company adopted a cryptocurrency treasury reserve strategy in September 2025, purchasing BTC with existing cash reserves.